RETRACTED ARTICLE: Nanoscale drug delivery strategies for therapy of ovarian cancer: conventional vs targeted-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

RETRACTED ARTICLE: Nanoscale drug delivery strategies for therapy of ovarian cancer: conventional vs targeted

Published:2019-10-18 Issue:1 Volume:47 Page:4066-4088
ISSN:2169-1401
Container-title:Artificial Cells, Nanomedicine, and Biotechnology
language:en
Short-container-title:Artificial Cells, Nanomedicine, and Biotechnology

Author:

Gupta Swati¹,Pathak Yashwant²³,Gupta Manish K.⁴,Vyas Suresh P.⁵

Affiliation:

1. Amity Institute of Pharmacy, Amity University Uttar Pradesh, Noida, India;

2. College of Pharmacy, University of South Florida Health, Tampa, FL, USA;

3. Faculty of Pharmacy, University of Airlangga, Surabaya, Indonesia;

4. TERI-Deakin Nanobiotechnology Centre, The Energy and Resources Institute (TERI), Gual Pahari, TERI Gram, Gurugram, India;

5. Department of Pharmaceutical Sciences, Dr H.S. Gour University, Sagar, India

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Biomedical Engineering,General Medicine,Medicine (miscellaneous),Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21691401.2019.1677680

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Review on Current Treatments and Challenges Involved in the Treatment of Ovarian Cancer;Current Cancer Drug Targets;2024-02

2. Engineering extracellular vesicles mimetics for targeted chemotherapy of drug-resistant ovary cancer;Nanomedicine;2024-01

3. Nano-drug delivery systems based on biodegradable polymers for the therapy of gynecological malignancies;International Journal of Polymeric Materials and Polymeric Biomaterials;2023-09-29

4. Engineered nanostructures: an introduction;Engineered Nanostructures for Therapeutics and Biomedical Applications;2023

5. MULTIFUNCTIONAL NANOSYSTEMS BASED ON TWO FLUORESCENT DYES, DOXORUBICIN AND CURCUMIN;Biotechnologia Acta;2022-12-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3